Sanofi-AventisParis, France (NYSE: SNY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Company Description

Sanofi-Aventis helps docs treat their sneezy patients without making them grumpy or dopey. The maker of allergy medicine Allegra specializes in...

Headquarters:

174 avenue de France
75013 Paris, France (Map)

Key Sanofi-Aventis Financials

Company Type Public - NYSE: SNY; Euronext Paris: SAN
Main Headquarters
Fiscal Year-End December
2008 Sales (mil.) $40,057.0
2008 Employees 98,213

Latest Sanofi-Aventis Jobs jobs by Indeed

Rankings

  • CAC 40
  • Dow Jones Global Titans
  • Dow Jones STOXX 50
  • Euronext 100
  • #46 in FT Global 500
  • SBF 120
  • SBF 250

Competition

Competitive Landscape for Pharmaceuticals Manufacture

Demand for pharmaceutical manufacture is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs. Large...

Top Sanofi-Aventis Competitors

Sanofi-Aventis Executives

Title Name & Bio Contact
Chairman Jean-François Dehecq Network
CEO Chris Viehbacher Network
EVP and CFO Jérôme Contamine Network
Searching for B2B Sales Leads?
With Hoover's Lead Builder, you can build, purchase, and download accurate, up-to-date lists of business leads for your direct mail and telemarketing campaigns.
Tools from our advertising partners:
Start A Franchise FedEx

Latest Sanofi-Aventis Video

  • interviewee
    SNY CEO on H1N1, Earnings (3:49)
    10/30/09 9:44ET - Sanofi sees Q4 H1N1 vacccine sales of around $500 million, with Chris Viehbacher, Sanofi-Aventis CEO and CNBC's Mike Huckman.


Copyright © 2009, Hoover's, Inc., All Rights Reserved. Legal Terms | Privacy Policy